Compare DERM & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | WALD |
|---|---|---|
| Founded | 2014 | 1988 |
| Country | United States | United Kingdom |
| Employees | N/A | 364 |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.9M | 187.3M |
| IPO Year | 2021 | N/A |
| Metric | DERM | WALD |
|---|---|---|
| Price | $6.68 | $1.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $12.67 | $2.00 |
| AVG Volume (30 Days) | 356.1K | ★ 664.0K |
| Earning Date | 05-13-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,858,000.00 | N/A |
| Revenue This Year | $39.72 | $9.89 |
| Revenue Next Year | $63.24 | $4.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $0.72 |
| 52 Week High | $9.56 | $3.22 |
| Indicator | DERM | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 53.44 | 53.23 |
| Support Level | $5.80 | $1.47 |
| Resistance Level | $8.23 | $1.95 |
| Average True Range (ATR) | 0.47 | 0.14 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 56.00 | 55.00 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.